Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Inspire prepares to submit NDA for diquafosol by mid-2003

Jan. 14, 2003

Restasis receives FDA approval

Jan. 7, 2003

FDA approval for Xalatan as first-line therapy for elevated IOP

Jan. 2, 2003

Pfizer and Eyetech form collaboration to develop and commercialize Macugen

Dec. 30, 2002

Statistically significant preliminary results in Visudyne study in minimally classic wet AMD

Dec. 27, 2002

Moxifloxacin NDA filed for bacterial conjunctivitis and ophthalmia neonatorum

Dec. 20, 2002

Advanced Biotherapy prepares IND for corneal transplant rejection therapy

Dec. 11, 2002

Phase II Posurdex trial in persistent macular edema completes enrollment

Dec. 11, 2002

INS-37217, a P2Y2 receptor agonist, enhances subretinal fluid reabsorption in preclinical models

Dec. 3, 2002

Asahi Glass patents new prostaglandin analogues with utility in glaucoma Rx

Dec. 3, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...